RxDoctor Payments Data

Barry Ford, MD

Family Medicine · Little Rock, ARNPI 1982698965

Payments from drug & device makers

$6,491in general payments, 2019–2025

Across 462 payments — averaging $14.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • GSK$1K
  • Astellas Pharma US Inc$698
  • Amgen$644
  • Merck$374
  • Pfizer$322
  • plus $2K from 34 others

What the payments were for

  • Food & beverage$6,491100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,491 in reported general payments places this provider in the 85th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$166,267
Medicare patients
541
Services billed
20,896

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide64$63,054
MounjaroTirzepatide55$54,642
Trelegy ElliptaFluticasone/Umeclidin/Vilanter75$48,188
JardianceEmpagliflozin47$33,330
EliquisApixaban51$28,579
JanuviaSitagliptin Phosphate30$23,341
FarxigaDapagliflozin Propanediol23$18,447
MyrbetriqMirabegron26$12,193
Breo ElliptaFluticasone/Vilanterol21$11,870
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr21$8,584
JentaduetoLinagliptin/Metformin Hcl13$6,437
Levothyroxine Sodium605$5,870
Xigduo XrDapaglifloz Propaned/Metformin12$5,721
SynthroidLevothyroxine Sodium96$5,563
Atorvastatin Calcium547$4,285

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$1,279$68,642117 claims
Novo NordiskOzempic$296$63,05464 claims
Lilly USA, LLCMounjaro, Olanzapine$197$56,56387 claims
Boehringer IngelheimJardiance, Jentadueto, Synjardy Xr$114$43,19772 claims
PfizerEliquis$322$28,57951 claims
MerckJanuvia$374$23,34130 claims
AstraZenecaFarxiga, Symbicort$126$21,18935 claims
Astellas Pharma US IncMyrbetriq$698$12,19326 claims
AbbVieSynthroid$1,306$5,56396 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →